Amgen Inc.
AMGN
$336.74
$0.740.22%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 34.50B | 33.51B | 32.78B | 32.03B | 31.14B |
| Total Other Revenue | 1.47B | 1.41B | 1.35B | 1.40B | 1.39B |
| Total Revenue | 35.97B | 34.92B | 34.13B | 33.42B | 32.53B |
| Cost of Revenue | 8.73B | 8.64B | 8.54B | 8.44B | 10.19B |
| Gross Profit | 27.24B | 26.28B | 25.58B | 24.98B | 22.35B |
| SG&A Expenses | 6.98B | 6.88B | 6.98B | 7.10B | 7.01B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 92.00M | 234.00M | 39.00M | 46.00M | -797.00M |
| Total Operating Expenses | 22.66B | 22.16B | 21.66B | 21.55B | 22.17B |
| Operating Income | 13.32B | 12.76B | 12.46B | 11.87B | 10.36B |
| Income Before Tax | 8.24B | 7.42B | 6.65B | 4.61B | 4.68B |
| Income Tax Expenses | 1.24B | 805.00M | 717.00M | 519.00M | 449.00M |
| Earnings from Continuing Operations | 7.01K | 6.62K | 5.93K | 4.09K | 4.23K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.01B | 6.62B | 5.93B | 4.09B | 4.23B |
| EBIT | 13.32B | 12.76B | 12.46B | 11.87B | 10.36B |
| EBITDA | 18.64B | 18.17B | 17.93B | 17.36B | 15.80B |
| EPS Basic | 13.02 | 12.31 | 11.04 | 7.62 | 7.88 |
| Normalized Basic EPS | 12.69 | 11.91 | 11.31 | 10.69 | 8.56 |
| EPS Diluted | 12.94 | 12.23 | 10.96 | 7.55 | 7.81 |
| Normalized Diluted EPS | 12.60 | 11.81 | 11.22 | 10.61 | 8.49 |
| Average Basic Shares Outstanding | 2.15B | 2.15B | 2.15B | 2.15B | 2.15B |
| Average Diluted Shares Outstanding | 2.17B | 2.17B | 2.17B | 2.16B | 2.16B |
| Dividend Per Share | 9.39 | 9.26 | 9.13 | 9.00 | 8.88 |
| Payout Ratio | 72.03% | 75.15% | 82.64% | 118.14% | 112.70% |